内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 KSThR共识声明：多普勒超声检查在甲状腺疾病中的临床应用

2020-08-25 韩国甲状腺放射学会 Ultrasonography . 2020 Aug 25.

甲状腺多普勒超声

2020年8月，韩国甲状腺放射学会(KSThR)发布了多普勒超声检查在甲状腺疾病中的临床应用共识声明。多普勒超声检查广泛用于甲状腺结节、甲状腺癌患者颈淋巴结转移以及弥漫性实质性疾病的鉴别诊断，还包括超

中文标题：

2018 KSThR共识声明：多普勒超声检查在甲状腺疾病中的临床应用

英文标题：

Clinical applications of Doppler ultrasonography for thyroid disease: consensus statement by the Korean Society of Thyroid Radiology

发布机构：

韩国甲状腺放射学会

发布日期：

2020-08-25

简要介绍：

2020年8月，韩国甲状腺放射学会(KSThR)发布了多普勒超声检查在甲状腺疾病中的临床应用共识声明。多普勒超声检查广泛用于甲状腺结节、甲状腺癌患者颈淋巴结转移以及弥漫性实质性疾病的鉴别诊断，还包括超声引导下的各种操作，包括活检和消融治疗。本文主要针对多普勒超声检查在甲状腺疾病中的临床应用提供共识声明。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2018 KSThR共识声明：多普勒超声检查在甲状腺疾病中的临床应用.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a86551c0019e29d6, title=2018 KSThR共识声明：多普勒超声检查在甲状腺疾病中的临床应用, enTitle=Clinical applications of Doppler ultrasonography for thyroid disease: consensus statement by the Korean Society of Thyroid Radiology, guiderFrom=Ultrasonography . 2020 Aug 25., authorId=0, author=, summary=2020年8月，韩国甲状腺放射学会(KSThR)发布了多普勒超声检查在甲状腺疾病中的临床应用共识声明。多普勒超声检查广泛用于甲状腺结节、甲状腺癌患者颈淋巴结转移以及弥漫性实质性疾病的鉴别诊断，还包括超, cover=https://img.medsci.cn/2020920/1600612960786_2020535.jpg, journalId=0, articlesId=null, associationId=1341, associationName=韩国甲状腺放射学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 25 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，韩国甲状腺放射学会(KSThR)发布了多普勒超声检查在甲状腺疾病中的临床应用共识声明。多普勒超声检查广泛用于甲状腺结节、甲状腺癌患者颈淋巴结转移以及弥漫性实质性疾病的鉴别诊断，还包括超声引导下的各种操作，包括活检和消融治疗。本文主要针对多普勒超声检查在甲状腺疾病中的临床应用提供共识声明。</p> </div> </div> </div>, tagList=[TagDto(tagId=736, tagName=甲状腺), TagDto(tagId=55745, tagName=多普勒超声)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=736, guiderKeyword=甲状腺, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3270, appHits=166, showAppHits=0, pcHits=572, showPcHits=3104, likes=5, shares=12, comments=10, approvalStatus=1, publishedTime=Sun Sep 20 23:45:29 CST 2020, publishedTimeString=2020-08-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 20 22:42:48 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 07:16:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2018 KSThR共识声明：多普勒超声检查在甲状腺疾病中的临床应用.pdf)])
2018 KSThR共识声明：多普勒超声检查在甲状腺疾病中的临床应用.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214048, encodeId=e9ce121404801, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=264a2713725, createdName=693086136, createdTime=Mon Apr 25 09:08:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193065, encodeId=5296119306523, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLsia5hqVlTLnicDMGialOZUKFCT3OXj9vRiblx5ic7WCFF6T6ibqtJLLUosnZmgg32Ilrm8d8ic41S1SEQQ/132, createdBy=fa022139687, createdName=小冉冉啦, createdTime=Sun Feb 13 19:55:35 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055686, encodeId=4b5f1055686b1, content=积分积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:35 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055685, encodeId=78001055685fa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:23 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962058, encodeId=9672962058ee, content=指南非常好，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2f5490594, createdName=ms5000001522213055, createdTime=Sat May 01 01:00:23 CST 2021, time=2021-05-01, status=1, ipAttribution=)]
    2022-04-25 693086136

    ***

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214048, encodeId=e9ce121404801, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=264a2713725, createdName=693086136, createdTime=Mon Apr 25 09:08:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193065, encodeId=5296119306523, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLsia5hqVlTLnicDMGialOZUKFCT3OXj9vRiblx5ic7WCFF6T6ibqtJLLUosnZmgg32Ilrm8d8ic41S1SEQQ/132, createdBy=fa022139687, createdName=小冉冉啦, createdTime=Sun Feb 13 19:55:35 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055686, encodeId=4b5f1055686b1, content=积分积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:35 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055685, encodeId=78001055685fa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:23 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962058, encodeId=9672962058ee, content=指南非常好，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2f5490594, createdName=ms5000001522213055, createdTime=Sat May 01 01:00:23 CST 2021, time=2021-05-01, status=1, ipAttribution=)]
    2022-02-13 小冉冉啦

    积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214048, encodeId=e9ce121404801, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=264a2713725, createdName=693086136, createdTime=Mon Apr 25 09:08:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193065, encodeId=5296119306523, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLsia5hqVlTLnicDMGialOZUKFCT3OXj9vRiblx5ic7WCFF6T6ibqtJLLUosnZmgg32Ilrm8d8ic41S1SEQQ/132, createdBy=fa022139687, createdName=小冉冉啦, createdTime=Sun Feb 13 19:55:35 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055686, encodeId=4b5f1055686b1, content=积分积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:35 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055685, encodeId=78001055685fa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:23 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962058, encodeId=9672962058ee, content=指南非常好，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2f5490594, createdName=ms5000001522213055, createdTime=Sat May 01 01:00:23 CST 2021, time=2021-05-01, status=1, ipAttribution=)]
    2021-09-28 ms1000000969751757

    积分积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214048, encodeId=e9ce121404801, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=264a2713725, createdName=693086136, createdTime=Mon Apr 25 09:08:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193065, encodeId=5296119306523, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLsia5hqVlTLnicDMGialOZUKFCT3OXj9vRiblx5ic7WCFF6T6ibqtJLLUosnZmgg32Ilrm8d8ic41S1SEQQ/132, createdBy=fa022139687, createdName=小冉冉啦, createdTime=Sun Feb 13 19:55:35 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055686, encodeId=4b5f1055686b1, content=积分积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:35 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055685, encodeId=78001055685fa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:23 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962058, encodeId=9672962058ee, content=指南非常好，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2f5490594, createdName=ms5000001522213055, createdTime=Sat May 01 01:00:23 CST 2021, time=2021-05-01, status=1, ipAttribution=)]
    2021-09-28 ms1000000969751757

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214048, encodeId=e9ce121404801, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=264a2713725, createdName=693086136, createdTime=Mon Apr 25 09:08:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193065, encodeId=5296119306523, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLsia5hqVlTLnicDMGialOZUKFCT3OXj9vRiblx5ic7WCFF6T6ibqtJLLUosnZmgg32Ilrm8d8ic41S1SEQQ/132, createdBy=fa022139687, createdName=小冉冉啦, createdTime=Sun Feb 13 19:55:35 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055686, encodeId=4b5f1055686b1, content=积分积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:35 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055685, encodeId=78001055685fa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47835471240, createdName=ms1000000969751757, createdTime=Tue Sep 28 13:55:23 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962058, encodeId=9672962058ee, content=指南非常好，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2f5490594, createdName=ms5000001522213055, createdTime=Sat May 01 01:00:23 CST 2021, time=2021-05-01, status=1, ipAttribution=)]
    2021-05-01 ms5000001522213055

    指南非常好，好好学习

    0

相关指南

2020年欧洲甲状腺协会在良性甲状腺结节中使用图像引导消融的临床实践指南

欧洲甲状腺协会(ETA,European Thyroid Association) · 2020-09-01

2020 ACOG实践简报：妊娠期甲状腺疾病（No.223）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2020-06-10

2019 KTA实践指南：甲状腺细针穿刺活检实践指南

韩国甲状腺放射学会(KSThR，Korean Society of Thyroid Radiology) · 2020-01-20

甲状腺及相关颈部淋巴结超声若干临床常见问题专家共识（2018版）

中国超声医学工程学会 浅表器官及外周血管超声专业委员会 · 2019-03-25

甲状腺及甲状旁腺术中喉上神经外支保护与监测专家共识（2017版）

中国医师协会外科医师分会 甲状腺外科医师委员会 · 2017-11-30

甲状腺外科能量器械应用专家共识（2017版）

中国医师协会外科医师分会 · 2017-09-30

拓展阅读

2009 ATA 甲状腺结节和分化型甲状腺癌指南修订版

美国甲状腺协会(ATA,American Thyroid Association) · 2009-12-01

2010AACE/AME/ETA 欧美甲状腺结节诊断和治疗临床指南

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2010-01-01

分化型甲状腺癌诊治指南

中国抗癌协会头颈肿瘤外科专业委员会 · 2010-10-01

2011 ATA实践建议：采用放射性131碘治疗的甲状腺疾病患者的辐射安全

美国甲状腺协会(ATA,American Thyroid Association) · 2011-03-18

2011ATA/AACE《甲亢和其他病因甲状腺毒症诊治指南》

美国甲状腺协会(ATA,American Thyroid Association) · 2011-06-01

2011 中国先天性甲状腺功能减低症诊疗共识

中华医学会儿科学分会内分泌遗传代谢学组 · 2011-06-01